Diagnosis and initial treatment of transplant-eligible high-risk myeloma patients: BSH Good Practice Paper
The British Society for Haematology (BSH) and the UK Myeloma Society have published a comprehensive Good Practice Paper on the diagnosis and initial treatment of transplant-eligible high-risk myeloma patients. Authored by leading experts in the field, this paper provides crucial recommendations based on the latest genetic diagnostics and prospective clinical trial evidence for high-risk myeloma.…